9-11 September 2026 | Marina Bay Sands, Singapore

10 September 2026

2:00 pm - 4:30 pm
Conference Hall 1, Hall D, Level B2

Medical Manufacturing Asia Forum

The MedTech industry is navigating increasing regulatory complexity, evolving supply chains, and rapid technological advancements. Staying competitive requires strategic insight, innovation, and the ability to adapt to a changing manufacturing landscape.

The Medical Manufacturing Asia (MMA) Forum brings together APAC’s leading manufacturers, innovators, start-ups, investors, and ecosystem partners to explore opportunities across MedTech production and commercialization.

Join us to experience a dynamic series of talks presented by the Singapore Precision Engineering and Technology Association (SPETA), featuring leading voices from Singapore’s MedTech and medical manufacturing sectors. Hear from C-suite leaders as they share practical strategies to future-proof your organisation, navigate evolving regulatory requirements, and address key challenges shaping the industry.

Medical Manufacturing Asia Forum

10 September 2026

2:30 pm - 5:00 pm

The MedTech industry is navigating increasing regulatory complexity, evolving supply chains, and rapid technological advancements. Staying competitive requires strategic insight, innovation, and the ability to adapt to a changing manufacturing landscape.

The Medical Manufacturing Asia (MMA) Forum brings together APAC’s leading manufacturers, innovators, start-ups, investors, and ecosystem partners to explore opportunities across MedTech production and commercialization.

Join us to experience a dynamic series of talks presented by the Singapore Precision Engineering and Technology Association (SPETA), featuring leading voices from Singapore’s MedTech and medical manufacturing sectors. Hear from C-suite leaders as they share practical strategies to future-proof your organisation, navigate evolving regulatory requirements, and address key challenges shaping the industry

Key Insights

Through expert-led sessions and case studies, attendees will gain perspectives on

AI-driven manufacturing

Resilient supply chains

Strategic partnerships

Emerging regulatory framework

Agenda on 10 Sep 2026, Thursday | 2:00 pm - 4:30 pm

*This is a preliminary agenda and subject to changes

2:00 pm – 2:05 pm

Opening by Singapore Precision Engineering and Technology Association (SPETA)

Jimmy Leong

Project Manager, Singapore Precision Engineering and Technology Association (SPETA)

2:05 pm – 2:25 pm

Scaling AI with Trust: Enabling Human-Centric Manufacturing

Dr Xu Chi

Deputy Division Director, Digital Manufacturing Division
Singapore Institute of Manufacturing Technology (SIMTech) & Advanced Remanufacturing Technology Centre (ARTC), A*STAR

2:25 pm – 2:45 pm

Strategic Innovation Pathways: When to Build, Outsource, Partner, or Acquire to De-Risk Medtech Manufacturing

Shameen Sazali

Programme Manager, Singapore Institute of Manufacturing Technology

2:45 pm – 3:05 pm

Reinventing MedTech Commercial Models – From Product Sales to Value-Based Services with AI-Enabled Insights

Yan Licheng

Digital Solution Consultant, Siemens

3:05 pm – 3:25 pm

AI in MedTech: Legal Risks & Pitfalls

Jonathan Teo

Senior Associate, Baker & McKenzie Wong & Leow

3:25 pm – 3:45 pm

Fostering MedTech Innovation – Strategic Investment Models, Partnerships and Ecosystem Enablement in Singapore

Willy Koh

CEO of Racer Technology and Leader of Singapore Medtech Consortium (SMC)

3:45 pm – 4:05 pm

Advancing Safe and Compliant AI-Enabled MedTech: ​Cybersecurity, and Wireless Coexistence

Cynthia Chuah

Strategic Program Manager for Digital Health, Keysight Technologies

4:05 pm – 4:30 pm

Moderated Q&A

Lim Ren Jun

(Moderator) Principal, Baker & McKenzie Wong & Leow

Who Should Attend

Designed for manufacturers, product owners, start-ups, and industry leaders, the forum offers practical insights to support innovation and market success in the evolving MedTech ecosystem.

The Forum is open to all registered Medical Manufacturing Asia Visitors.

Scroll to Top

Dr Xu Chi

Deputy Division Director, Digital Manufacturing Division

Singapore Institute of Manufacturing Technology (SIMTech) & Advanced Remanufacturing Technology Centre (ARTC), A*STAR

Dr Xu Chi is the Deputy Division Director of the Digital Manufacturing Division at A*STAR SIMTech and ARTC, where he oversees R&D strategy and drives capability development for advanced manufacturing. His work focuses on AI-driven predictive analytics and optimization for manufacturing, with solutions successfully deployed and licensed across various industry sectors.

Dr Xu serves as Principal Investigator (PI) or Co-PI on eight competitive research grants, with a total funding portfolio exceeding SGD 20 million. He is also an Adjunct Assistant Professor at the College of Computing and Data Science (CCDS), Nanyang Technological University (NTU), Singapore. He received both his PhD and Bachelor’s degree from NTU and has authored over 40 journal and conference publications, including leading AI venues such as NeurIPS, ICLR, IJCAI, ICML, EMNLP.

Shameen Sazali

Programme Manager, Singapore Institute of Manufacturing Technology

Shameen is the Programme Manager for SIMTech’s Innovation Factory (IF), overseeing programme delivery, governance and industry collaborations. She has extensive experience working with multidisciplinary teams and industry partners to translate innovative ideas into practical, deployable solutions that deliver meaningful industry impact.

Yan Licheng

Digital Solution Consultant, Siemens

Licheng is a Digital Solutions Consultant at Siemens, specializing in the convergence of Industrial AI and Operational Technology (OT) Cybersecurity. With a multidisciplinary background spanning engineering, automation, and artificial intelligence, he helps manufacturers accelerate digital transformation through secure, AI-driven industrial solutions.

At Siemens, Licheng leads strategic customer engagements and industry initiatives, advising organizations on the adoption of Industrial AI, Agentic AI, Large Language Models (LLMs), and OT cybersecurity. He is passionate about helping industrial enterprises harness trusted AI to enhance engineering productivity, optimize operations, and build resilient, future-ready manufacturing environments.

Jonathan Teo

Senior Associate, Baker & McKenzie Wong & Leow

Jonathan is a Senior Associate in Baker McKenzie Wong & Leow’s IPTech practice. Jonathan works closely with a range of clients in the healthcare industry, ranging from multinational pharmaceutical and medical device companies, biotech and medtech start-ups, to healthcare service providers. He advises keenly on healthcare regulatory issues, including market entry, compliance, commercial and contentious matters.

Willy Koh

CEO of Racer Technology and Leader of Singapore Medtech Consortium (SMC)

Founder of Racer Technology, Chairman of Singapore Medtech Consortium, Deputy Chairman of SPETA, Member of International Judging Panel for Lee Kuan Yew Global Business Plan

Cynthia Chuah

Strategic Program Manager for Digital Health, Keysight Technologies

Cynthia Chuah is Keysight’s Strategic Program Manager for Digital Health, leading the healthcare-focused go-to-market strategy. She works closely with medical device manufacturers and healthcare innovators to advance connected and AI-enabled healthcare solutions. Her expertise spans wireless medical device validation, wireless coexistence testing, manufacturing test strategies, and end-to-end test solution, helping organizations address the safety, reliability, and performance requirements of next-generation medical devices and healthcare systems. With over 20 years of experience in the Test & Measurement industry, Cynthia brings a strong track record across R&D, system application engineering, and strategic marketing

Lim Ren Jun

(Moderator) Principal, Baker & McKenzie Wong & Leow

Ren Jun is a Principal at Baker McKenzie Wong & Leow’s IPTech practice and co-leads the Healthcare & Life Sciences industry group. He also leads the Firm’s regional Regulatory group. Ren Jun advises local and international clients on contentious and non-contentious IP and technology matters. He also advises on a full range of commercial, regulatory and compliance issues in the healthcare industry.